Publication:
One centered, randomized, double blind, phase III clinical trial comparing the effects of 1 mg/day oral colchicine and placebo being received for 3 months on pain, stiffness and physical function in patients with mild-severe knee osteoarthritis at primary care

dc.contributor.authorSUR ÜNAL, ÜLKÜ
dc.contributor.authorÇİFÇİLİ, SALİHA SERAP
dc.contributor.authorsSUR ÜNAL Ü., ÇİFÇİLİ S. S.
dc.date.accessioned2023-01-26T06:58:50Z
dc.date.accessioned2026-01-10T16:51:43Z
dc.date.available2023-01-26T06:58:50Z
dc.date.issued2015-10-19
dc.identifier.citationSUR ÜNAL Ü., ÇİFÇİLİ S. S., \"One centered, randomized, double blind, phase III clinical trial comparing the effects of 1 mg/day oral colchicine and placebo being received for 3 months on pain, stiffness and physical function in patients with mild-severe knee osteoarthritis at primary care\", European General Practice Research Network, 17 - 20 Ekim 2015
dc.identifier.urihttps://hdl.handle.net/11424/285889
dc.language.isoeng
dc.relation.ispartofEuropean General Practice Research Network
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleOne centered, randomized, double blind, phase III clinical trial comparing the effects of 1 mg/day oral colchicine and placebo being received for 3 months on pain, stiffness and physical function in patients with mild-severe knee osteoarthritis at primary care
dc.typeconferenceObject
dspace.entity.typePublication

Files